Weili Li

ORCID: 0000-0003-0886-7330
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Cerebrovascular and Carotid Artery Diseases
  • Abdominal vascular conditions and treatments
  • Stroke Rehabilitation and Recovery
  • Cerebral Venous Sinus Thrombosis
  • Intracranial Aneurysms: Treatment and Complications
  • Barrier Structure and Function Studies
  • Renal and Vascular Pathologies
  • High Altitude and Hypoxia
  • Cardiovascular and Diving-Related Complications
  • Aortic aneurysm repair treatments
  • Neurological Disease Mechanisms and Treatments

Shandong Provincial QianFoShan Hospital
2024-2025

Shandong First Medical University
2024-2025

Capital Medical University
2024-2025

Ministry of Science and Technology
2024

Dumfries and Galloway Royal Infirmary
2011

University of Exeter
2011

This study investigated the efficacy and safety of endovascular revascularization for symptomatic non-acute atherosclerotic intracranial LVO. For large vessel occlusion (LVO), despite aggressive medical treatment, recurrent ischemic stroke or transient attack related to occluded artery still occurs repeatedly. retrospective cohort included patients with LVO who received treatment (EVT), categorized by successful recanalization time interval from symptom onset (<30 days vs. ≥ 30 days). The...

10.5551/jat.65539 article EN Journal of Atherosclerosis and Thrombosis 2025-01-01

Normobaric hyperoxia (NBO) has neuroprotective effects in acute ischemic stroke. Thus, we aimed to identify the optimal NBO treatment duration combined with endovascular treatment.

10.1161/strokeaha.123.046106 article EN Stroke 2024-05-15

Abstract: INTRODUCTION: Ongoing research endeavors seek to identify neuroprotective drugs capable of mitigating brain cell necrosis and reperfusion injury by protecting the ischemic penumbra. Despite these efforts, quest for effective agents remains elusive. Encouragingly, preliminary investigations, including basic experiments single-center exploratory studies, have demonstrated properties normobaric hyperoxia (NBO). In pursuit validating expanding upon findings, we conducted a multicenter,...

10.4103/bc.bc_29_24 article EN cc-by-nc-sa Brain Circulation 2025-03-31

Vessel wall MRI (VWMRI) can reveal the morphological features of intracranial artery occlusion (ICAO). This study aimed to investigate imaging ICAO on VWMRI and explore their correlation with perioperative complications endovascular recanalization for non-acute ICAO. The retrospectively included consecutive patients recurrent ischemic stroke due in anterior circulation who underwent preoperative evaluation recanalization. Perioperative hemorrhagic strokes within 30 days after operation....

10.1136/jnis-2024-022413 article EN Journal of NeuroInterventional Surgery 2024-12-18

BACKGROUND Recent advancements in animal studies have demonstrated the potential of normobaric hyperoxia (NBO) as a promising intervention for preserving integrity blood–brain barrier (BBB). However, there is still limited understanding effects NBO on BBB function patients with clinical stroke. Therefore, objective this study was to investigate efficacy therapy attenuating damage and reducing brain injury individuals undergoing endovascular treatment (EVT) acute METHODS AND RESULTS This...

10.1161/jaha.124.036474 article EN cc-by-nc-nd Journal of the American Heart Association 2024-10-18

Although, atherosclerotic renovascular disease (ARVD) is an important cause of acute pulmonary oedema (APO) and congestive heart failure (CHF) it unclear whether best treatment for ARVD with APO or CHF should be medical therapy only revascularization.1 The randomized controlled trials do not help here as they exclude failure.2 Evidence in favour revascularization comes from case reports3 observational studies patients APO4–6 CHF7,8 impressive improvements reported symptoms, blood pressure...

10.1093/qjmed/hcr068 article EN QJM 2011-05-09
Coming Soon ...